A Comparison of Abrasion Arthroplasty and Subchondral Microfracture in the Treatment of Chondral and Osteochondral Cartilage Lesions in the Rabbit
World Small Animal Veterinary Association World Congress Proceedings, 2004
V. Ledecky, S. Hornak, K. Ledecka, M. Hluchy

Introduction

The purpose of this study was to observe the difference in healing of chondral and osteochondral defects treated with abrasion arthroplasty versus subchondral microfracture.

Material and methods

8 rabbits were divided in two groups (4 rabbits in group A and 4 rabbits in group B). In both groups, a 3.0 mm diameter defect was created on medial and lateral femoral condyles. In group A cartilage was shaved without penetrating the subchondral plate. In group B, defects were created into subchondral bone (3.0 mm deep). In each medial epicondyle defects, two 1.0 mm holes were performed into subchondral bone with orthopedic awl until bleeding was observed. Each lateral epicondyle defects underwent a abrasion arthroplasty until punctate bleeding was observed. Joint resurfacing and degenerative changes were evaluated grossly and histologically after 8 and 12 weeks.

Results

On gross observation a greater volume of repair tissue filled treated defects. Degenerative changes in the cartilage surface were observed in both groups with both treatments. No differences in repair score of osteochondral defects were observed. In chondral defects, defects undergoing microfracture technique had increased repair score than defects treated with abrasion arthroplasty.

Conclusion

Both techniques have potential for repair chondral and osteochondral cartilage defects. Histological evidence at 12 weeks suggests that microfracture technique may result in better repair than abrasion arthroplasty in the treatment of chondral cartilage defect.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

V. Ledecky


MAIN : Abstracts : Abrasion Arthroplasty and Subchondral Microfracture
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27